Those worst affected by any ailment are usually the ones who go the furthest in order to defend themselves against it. Areas prone to flooding have the greatest flood defences and those in natural earthquake zones have structurally designed buildings. Sure, there are limiting factors to this axiom such as affordability and availability but it’s still a pretty accurate rule. So why then has the United States, the country with the highest number of infections across the whole globe, secured so few doses of the vaccine?
In the world of vaccination it’s all about big numbers. One dose per head is rarely sufficient in order to generate sufficient immunity within a population. Nations including the United Kingdom, Canada and Australia therefore have ordered enough doses of approved and pending vaccines to inoculate their populations several times over. Canada alone has enough doses secured in its contracts to provide a dose to each of its citizens four times over – anti-vaxxer or not! The US acquiring programme on the other hand, ironically dubbed Operation Warp Speed, has only secured one third of this number of doses as a proportion of its population versus coverage leader, Canada. Despite not having approved a single vaccine in the United States, the potential shortfall could undermine the nation in achieving immunity to the virus and stunt the economic bounce back from the pandemic.
The US has secured 455 million doses, considerably more than its population. However, the vaccine is thought to require a boost to sustain immunisation similar to the pre-existing flu jab, meaning that the US should be closer to 1bn doses before it might be considered to have enough. Given the finite capacity of all Covid-19 vaccine production, the fact the US is several dozen the way down the global pecking order for doses means it may struggle to scale up its vaccination program in a timely fashion. Pfizer has just cut its 2020 delivery target in half due to manufacturing issues and this is a timely reminder that shocks to global supplies of any vaccine will be felt harder in lesser covered nations. The vaccination program is something that President-elect Biden has suggested he will work on with immediate effect upon taking office. If insufficient coverage of a vaccine undermines US economic performance there could be an adverse reaction in US assets.
Discussion and Analysis by Charles Porter
Click Here to Subscribe to the SGM-FX Newsletter
Related Insights
Daily Brief – From minutes to CPI
Charles Porter
Thu 10 Oct 2024
From minutes to CPI If you are finding it harder than usual to digest the current financial climate then you are forgiven entirely. Almost intraday, sentiment is flipping between adjectives such as inflationary, deflationary, stagflationary, expansionary and contractionary to describe the same economic phenomena. That is largely being driven by a rapidly changing macro environment […]
Daily Brief – Overrated Rates
Charles Porter
Tue 1 Oct 2024
Overrated Rates The unwinding of USD implied short term interest rates shouldn’t be underestimated. Take a brief look at changes in FX swap pricing over the past few months and you’ll see just how significant those interest rate expectations have proved to be. Particularly within GBPUSD, the difference is enormous. Post-pandemic inflationary pressures affected the […]
Daily Brief – Nonstop flight to nowhere
Charles Porter
Tue 8 Oct 2024
Nonstop flight to nowhere And before you start wondering, no, this brief isn’t about some new route Qantas has launched to propel passengers an inconceivably long distance in one hit. What I refer to in the title of this briefing are the rapidly evolving growth and economic base case projections within the US. The debate […]
